유럽 ​​초음파 젤 시장 – 2029년까지의 산업 동향 및 예측

TOC 요청 TOC 요청 분석가에게 문의 분석가에게 문의 지금 구매 지금 구매 구매하기 전에 문의 구매하기 전에 문의 무료 샘플 보고서 무료 샘플 보고서

유럽 ​​초음파 젤 시장 – 2029년까지의 산업 동향 및 예측

  • Medical Devices
  • Published Report
  • Oct 2022
  • Europe
  • 350 Pages
  • 테이블 수: 154
  • 그림 수: 35

유럽 ​​초음파 젤 시장, 유형(멸균 및 비멸균), 응용 분야( 복부 초음파, 산부인과 초음파, 자궁 초음파, 골반 초음파, 근골격 초음파, 유방 초음파, 전립선 초음파, 경동맥 초음파, 정맥 초음파(사지), 고환 초음파, 갑상선 초음파 및 기타), 최종 사용자(병원, 진료소, 진단 센터, 외래 수술 센터 및 기타), 유통 채널(소매 판매, 온라인 판매 및 직접 입찰) - 업계 동향 및 2029년까지의 예측.

유럽 ​​초음파 젤 시장

유럽 ​​초음파 젤 시장 분석 및 통찰력

초음파 젤은 자궁초음파, 산부인과 초음파, 복부 초음파, 유방 초음파, 경동맥 초음파, 근골격계 초음파, 골반 초음파, 전립선 초음파, 고환 초음파, 갑상선 초음파, 정맥 초음파 등을 포함한 다양한 초음파 시술에 널리 사용되는 젤 중 하나입니다. 초음파 젤은 염증 증상 치료에 사용되는 항-TNF 약물입니다. 의료 전문가는 명확하고 정확한 진단을 위해 생물학적 초음파 젤을 사용합니다.

유럽 ​​초음파 젤 시장

유럽 ​​초음파 젤 시장

유럽 ​​초음파 젤 시장은 2022년부터 2029년까지의 예측 기간 동안 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 시장이 2022년부터 2029년까지의 예측 기간 동안 6.1%의 CAGR로 성장하고 있으며 2029년까지 39,078.25천 달러에 도달할 것으로 분석합니다.

보고서 메트릭

세부

예측 기간

2022년부터 2029년까지

기준 연도

2021

역사적 연도

2020 (2019-2014 사용자 정의 가능)

양적 단위

수익 (USD 천)

다루는 세그먼트

유형별(멸균 및 비멸균), 적용 분야별(복부 초음파, 산부인과 초음파, 자궁초음파, 골반 초음파, 근골격 초음파, 유방 초음파, 전립선 초음파, 경동맥 초음파, 정맥 초음파(사지), 고환 초음파, 갑상선 초음파 및 기타), 최종 사용자별(병원, 진료소, 진단 센터, 외래 수술 센터 및 기타), 유통 채널별(소매 판매, 온라인 판매 및 직접 입찰)

적용 국가

독일, 프랑스, ​​영국, 이탈리아, 스페인, 네덜란드, 스위스, 벨기에, 터키 및 유럽의 나머지 지역

시장 참여자 포함

시장에서 운영되는 주요 회사로는 Medline Industries LP, Deas srl, HR Pharmaceuticals Inc, FIAB SpA, Gima SpA, Parker Laboratories Inc, Primax Berlin GmbH, Optimum Medical Limited, Safersonic, Braun and Co. Limited, ProSys International Ltd, Turquoise Health, DJO LLC, Fannin, Lessa(AB Medica Group 자회사), Rays SPA 등이 있습니다.

 시장 정의:

Ultrasound gels are one of the most commonly used gels during ultrasound procedures. Ultrasound gels are used to get clear and precise imaging during diagnostics. These are the type of conductive medium applied to the skin and act as a coupling agent and therefore help form a tight bond between the skin and the probe. This gel also helps ultrasound waves to convey straight to the tissues and other parts where imaging is required.

Ultrasound Gels Market Dynamics

Drivers

  • Rising Ultrasound Procedures

High-frequency sound waves perform an ultrasound scan to image a person's internal body structures. Doctors or clinicians apply ultrasound gels on a patient's body parts for deep, precise and clear medical imaging. As growing technology enables high-resolution images in medical ultrasound, it is becoming easier to diagnose the internal body correctly. Due to its cost-effective nature and increased awareness regarding periodical check-ups for healthier bodies, the number of ultrasound scans is rising. Ultrasounds gels are the most convenient and reliable product during these scans. The dependency of clinicians and doctors on ultrasounds has increased regularly. These procedures are commonly used to examine the liver, kidneys and other organs in the stomach, pelvis and other organs or tissues that can be assessed through the skin. Rise in geriatric population

  • Easy Usage and Patient-Friendly Diagnosis

When scanning, ultrasound gels are most often used by clinicians, doctors and medical staff as these gels help prevent air between the ultrasonic waves from the scanner to the gel-applied body part. Most ultrasound procedures are painless as they are non-invasive and are done externally, only the gels are applied to the body and the transducer is placed nearby contact with the skin as it passes light waves, which gives negligible effect on the person's body. Ultrasound procedures use high-frequency sound waves to create an image of part of the inside of the body, as ultrasound gels best capture these images. These gels applied on the skin are easy to use and do not cause any body pain. Therefore, the easy and painless ultrasound procedure will aid in the growth of the market in the forecast period

유럽 ​​초음파 젤 시장

Opportunities

  • The Rise In Healthcare Expenditure

Healthcare expenditure has increased worldwide as people's disposable income in various countries increases. Moreover, to accomplish the population requirements, government bodies and healthcare organizations are taking the initiative by virtue of accelerating healthcare expenditure. Also, the rise in healthcare expenditure by the government in the region will provide structural integrity and future opportunities for the ultrasound gels market in the forecast period of 2022-2029.

Restraints/Challenges

There are various and several skin problems and allergies are reported due to the usage of ultrasound gels. Some develop these problems because of their sensitive skin. Contact dermatitis has occurred in a small population of patients due to ultrasound gels use. Other Bacterial contamination may also develop sometimes on the patient's skin where the gels are being applied. Some formulations or different compositions of gels heat up when treated under UV light due to exothermic reaction. The thicker the gels could be, the more heat is produced. Hence, the side effects associated with using ultrasound gels may hamper the market growth in the forecast period.

Post-COVID-19 Impact on Europe Ultrasound Gels market

COVID-19 has affected the growth of the market as there is a rise in the ultrasound procedures in the region, such as hysterosonography, obstetric ultrasound, abdominal ultrasound, breast ultrasound, carotid ultrasound, musculoskeletal ultrasound, pelvic ultrasound, prostate ultrasound, scrotal ultrasound, thyroid ultrasound, venous ultrasound, others. Hence, the need for the ultrasound gels keeps rising during the COVID period.

Recent Development

  • In April 2019, Civco Medical Solutions launched a new solution—Envision Viral Barrier—that eliminates the use of gels in ultrasound procedures. This product consists of an ultrasound probe cover and a scanning pad with a sterile liquid that facilitates 100% gel-free procedures. Such technological advancements help reduce the risk of contamination and ease clinician workflows in healthcare settings, which may impede the market growth

Europe Ultrasound Gels Market Scope

Europe ultrasound gels market is segmented into type, application, end-user and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.

Application

  • Abdominal Ultrasound
  • Obstetric Ultrasound
  • Hysterosonography
  • Pelvic Ultrasound
  • Musculoskeletal Ultrasound
  • Breast Ultrasound
  • Prostate Ultrasound
  • Carotid Ultrasound
  • Venous Ultrasound (Extremities)
  • Scrotal Ultrasound
  • Thyroid Ultrasound
  • Others

On the basis of application, the Europe ultrasound gels market is segmented into abdominal ultrasound, obstetric ultrasound, hysterosonography, pelvic ultrasound, musculoskeletal ultrasound, breast ultrasound, prostate ultrasound, carotid ultrasound, venous ultrasound (extremities), scrotal ultrasound, thyroid ultrasound and others.

Type

  • Sterile Ultrasound Gels
  • Non-Sterile Ultrasound Gels

On the basis of type, the Europe ultrasound gels market is segmented into sterile and non-sterile ultrasound gels.

End User

  • Hospitals
  • Clinics
  • Diagnostic Centers
  • Ambulatory Surgical Centers
  • Others

유럽 ​​초음파 젤 시장은 최종 사용자를 기준으로 병원, 진료소, 진단 센터, 외래 수술 센터 등으로 구분됩니다.

유통 채널

  • 소매 판매
  • 온라인 판매
  • 직접 입찰

유럽 ​​초음파 젤 시장

유럽 ​​초음파 젤 시장은 유통 채널을 기준으로 소매 판매, 온라인 판매, 직접 입찰로 구분됩니다.

시장 정의

초음파 젤은 일반적으로 사용되는 젤 중 하나이며 주로 초음파 시술 중에 사용됩니다. 초음파 젤은 진단 중에 선명하고 정확한 영상을 얻는 데 사용됩니다. 이는 피부에 적용되는 전도성 매체 유형이며 커플링제 역할을 하므로 피부와 프로브 사이에 긴밀한 결합을 형성하는 데 도움이 됩니다. 이 젤은 또한 초음파가 영상이 필요한 조직 및 기타 부위로 직접 전달되도록 돕습니다.

유럽 ​​초음파 젤 시장 지역 분석/통찰력     

위에서 언급한 대로, 초음파 젤 시장을 분석하고 국가, 유형, 응용 분야, 최종 사용자 및 유통 채널별로 시장 규모에 대한 통찰력과 추세를 제공합니다.

유럽 ​​초음파 젤 시장을 구성하는 국가로는 독일, 프랑스, ​​영국, 이탈리아, 스페인, 네덜란드, 스위스, 벨기에, 터키와 기타 유럽 국가가 있습니다.

독일은 시장 점유율과 시장 수익 측면에서 초음파 젤 시장을 지배하고 있으며 예측 기간 동안 지배력을 계속 확대할 것입니다. 이는 다양한 만성 질환의 유병률 증가와 독일의 약물 개발 연구 개발이 이 시장 성장을 더욱 개선하기 때문입니다.

보고서의 국가 섹션은 또한 현재 및 미래 시장 추세에 영향을 미치는 개별 시장 영향 요인과 시장 규정의 변화를 제공합니다. 신규 및 교체 판매, 국가 인구 통계, 질병 역학 및 수출입 관세와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 주요 포인터 중 일부입니다. 또한 글로벌 브랜드의 존재 및 가용성과 국내 및 국내 브랜드와의 치열한 경쟁으로 인해 직면한 과제, 판매 채널의 영향이 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.

경쟁 환경 및 시장 점유율 분석

초음파 젤 시장 경쟁 구도는 경쟁자에 대한 세부 정보를 제공합니다. 세부 정보에는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우위가 포함됩니다. 위의 데이터 포인트는 유럽 초음파 젤 시장에 대한 회사의 초점에만 관련이 있습니다.

유럽 ​​초음파 젤 시장의 주요 기업으로는 Medline Industries LP, Deas srl, HR Pharmaceuticals Inc, FIAB SpA, Gima SpA, Parker Laboratories Inc, Primax Berlin GmbH, Optimum Medical Limited, Safersonic, Braun and Co. Limited, ProSys International Ltd, Turquoise Health, DJO LLC, Fannin, Lessa(AB Medica Group 자회사), Rays SPA 등이 있습니다.

연구 방법론

데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석 및 추정됩니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 기본(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 회사 시장 점유율 분석, 측정 표준, 유럽 대 지역 및 공급업체 점유율 분석이 포함됩니다. 추가 문의 사항이 있는 경우 분석가에게 전화를 요청하십시오.


SKU-

세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요

  • 대화형 데이터 분석 대시보드
  • 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
  • 사용자 정의 및 질의를 위한 리서치 분석가 액세스
  • 대화형 대시보드를 통한 경쟁자 분석
  • 최신 뉴스, 업데이트 및 추세 분석
  • 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
데모 요청

목차

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE EUROPE ULTRASOUND GELS MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 TYPE LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 MARKET END-USER COVERAGE GRID

2.11 VENDOR SHARE ANALYSIS

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTEL ANALYSIS

4.2 PORTER'S FIVE FORCES MODEL

4.3 NUMBER OF ULTRASOUND PROCEDURES, BY COUNTRY

4.3.1 NUMBER OF ABDOMINAL ULTRASOUND PROCEDURES, BY COUNTRY

4.3.2 NUMBER OF OBSTETRIC ULTRASOUND PROCEDURES, BY COUNTRY

4.3.3 NUMBER OF HYSTEROSONOGRAPHY ULTRASOUND PROCEDURES, BY COUNTRY

4.3.4 NUMBER OF BREAST ULTRASOUND PROCEDURES, BY COUNTRY

4.3.5 NUMBER OF CAROTID ULTRASOUND PROCEDURES, BY COUNTRY

4.3.6 NUMBER OF MUSCULOSKELETAL ULTRASOUND PROCEDURES, BY COUNTRY

4.3.7 NUMBER OF PELVIC ULTRASOUND PROCEDURES, BY COUNTRY

4.3.8 NUMBER OF PROSTATE ULTRASOUND PROCEDURES, BY COUNTRY

4.3.9 NUMBER OF SCROTAL ULTRASOUND PROCEDURES, BY COUNTRY

4.3.10 NUMBER OF THYROID ULTRASOUND PROCEDURES, BY COUNTRY

4.3.11 NUMBER OF VENOUS (EXTREMITIES) ULTRASOUND PROCEDURES, BY COUNTRY

5 EUROPE ULTRASOUND GELS MARKET: REGULATIONS

5.1 REGULATION IN EUROPE

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 RISING ULTRASOUND PROCEDURES

6.1.2 EASY USAGE AND PATIENT-FRIENDLY PAINLESS DIAGNOSIS

6.1.3 VERSATILE IN NATURE, HAVE VARIOUS DIFFERENT FORMULATIONS

6.2 RESTRAINTS

6.2.1 UNPLEASANT SIDE EFFECTS SUCH AS ALLERGIES OR SKIN PROBLEMS

6.2.2 LOW-COST SUBSTITUTES

6.3 OPPORTUNITIES

6.3.1 RISE IN HEALTHCARE EXPENDITURE

6.3.2 STRATEGIC INITIATIVES OF KEY PLAYERS

6.3.3 DEVELOPMENT OF INNOVATIVE IMAGING MODALITIES AND CONTRAST AGENTS

6.4 CHALLENGES

6.4.1 UPCOMING TECHNOLOGICAL ADVANCEMENTS ELIMINATING THE USE OF ULTRASOUND GEL

6.4.2 RISK ASSOCIATED WITH USE OF NON-STERILE ULTRASOUND GEL IN GERIATRIC PATIENTS

7 EUROPE ULTRASOUND GELS MARKET, BY TYPE

7.1 OVERVIEW

7.2 NON-STERILE ULTRASOUND GELS

7.3 STERILE ULTRASOUND GELS

8 EUROPE ULTRASOUND GELS MARKET, BY APPLICATION

8.1 OVERVIEW

8.2 ABDOMINAL ULTRASOUND

8.2.1 NON-STERILE ULTRASOUND GELS

8.2.2 STERILE ULTRASOUND GELS

8.3 OBSTETRIC ULTRASOUND

8.3.1 NON-STERILE ULTRASOUND GELS

8.3.2 STERILE ULTRASOUND GELS

8.4 HYSTEROSONOGRAPHY

8.4.1 NON-STERILE ULTRASOUND GELS

8.4.2 STERILE ULTRASOUND GELS

8.5 PELVIC ULTRASOUND

8.5.1 NON-STERILE ULTRASOUND GELS

8.5.2 STERILE ULTRASOUND GELS

8.6 MUSCULOSKELETAL ULTRASOUND

8.6.1 NON-STERILE ULTRASOUND GELS

8.6.2 STERILE ULTRASOUND GELS

8.7 BREAST ULTRASOUND

8.7.1 NON-STERILE ULTRASOUND GELS

8.7.2 STERILE ULTRASOUND GELS

8.8 PROSTATE ULTRASOUND

8.8.1 NON-STERILE ULTRASOUND GELS

8.8.2 STERILE ULTRASOUND GELS

8.9 CAROTID ULTRASOUND

8.9.1 NON-STERILE ULTRASOUND GELS

8.9.2 STERILE ULTRASOUND GELS

8.1 VENOUS ULTRASOUND (EXTERMITIS)

8.10.1 NON-STERILE ULTRASOUND GELS

8.10.2 STERILE ULTRASOUND GELS

8.11 SCROTAL ULTRASOUND

8.11.1 NON-STERILE ULTRASOUND GELS

8.11.2 STERILE ULTRASOUND GELS

8.12 THYROID ULTRASOUND

8.12.1 NON-STERILE ULTRASOUND GELS

8.12.2 STERILE ULTRASOUND GELS

8.13 OTHERS

9 EUROPE ULTRASOUND GELS MARKET, BY END USER

9.1 OVERVIEW

9.2 HOSPITALS

9.3 DIAGNOSTIC CENTERS

9.4 CLINICS

9.5 AMBULATORY SURGICAL CENTERS

9.6 OTHERS

10 EUROPE ULTRASOUND GELS MARKET, BY DISTRIBUTION CHANNEL

10.1 OVERVIEW

10.2 RETAIL SALES

10.3 ONLINE SALES

10.4 DIRECT TENDER

11 EUROPE ULTRASOUND GELS MARKET, BY COUNTRY

11.1 GERMANY

11.2 FRANCE

11.3 U.K.

11.4 ITALY

11.5 TURKEY

11.6 SPAIN

11.7 NETHERLANDS

11.8 BELGIUM

11.9 SWITZERLAND

11.1 REST OF EUROPE

12 EUROPE ULTRASOUND GELS MARKET: COMPANY LANDSCAPE

12.1 COMPANY SHARE ANALYSIS: EUROPE

13 SWOT ANALYSIS

14 COMPANY PROFILE

14.1 PARKER LABORATORIES, INC.

14.1.1 COMPANY SNAPSHOT

14.1.2 PRODUCT PORTFOLIO

14.1.3 RECENT DEVELOPMENTS

14.2 OPTIMUM MEDICAL LIMITED

14.2.1 COMPANY SNAPSHOT

14.2.2 PRODUCT PORTFOLIO

14.2.3 RECENT DEVELOPMENTS

14.3 FIAB SPA

14.3.1 COMPANY SNAPSHOT

14.3.2 PRODUCT PORTFOLIO

14.3.3 RECENT DEVELOPMENTS

14.4 DEAS S.R.L.

14.4.1 COMPANY SNAPSHOT

14.4.2 PRODUCT PORTFOLIO

14.4.3 RECENT DEVELOPMENTS

14.5 HR PHARMACEUTICALS, INC.

14.5.1 COMPANY SNAPSHOT

14.5.2 PRODUCT PORTFOLIO

14.5.3 RECENT DEVELOPMENTS

14.6 BRAUN & CO. LIMITED

14.6.1 COMPANY SNAPSHOT

14.6.2 PRODUCT PORTFOLIO

14.6.3 RECENT DEVELOPMENTS

14.7 DJO, LLC

14.7.1 COMPANY SNAPSHOT

14.7.2 PRODUCT PORTFOLIO

14.7.3 RECENT DEVELOPMENTS

14.8 FANNIN

14.8.1 COMPANY SNAPSHOT

14.8.2 PRODUCT PORTFOLIO

14.8.3 RECENT DEVELOPMENTS

14.9 GIMA S.P.A.

14.9.1 COMPANY SNAPSHOT

14.9.2 PRODUCT PORTFOLIO

14.9.3 RECENT DEVELOPMENTS

14.1 LESSA (SUBSIDIARY OF AB MEDICA GROUP)

14.10.1 COMPANY SNAPSHOT

14.10.2 PRODUCT PORTFOLIO

14.10.3 RECENT DEVELOPMENTS

14.11 MEDLINE INDUSTRIES, LP.

14.11.1 COMPANY SNAPSHOT

14.11.2 PRODUCT PORTFOLIO

14.11.3 RECENT DEVELOPMENTS

14.12 PRIMAX BERLIN GMBH

14.12.1 COMPANY SNAPSHOT

14.12.2 PRODUCT PORTFOLIO

14.12.3 RECENT DEVELOPMENTS

14.13 PROSYS INTERNATIONAL LTD

14.13.1 COMPANY SNAPSHOT

14.13.2 PRODUCT PORTFOLIO

14.13.3 RECENT DEVELOPMENTS

14.14 RAYS S.P.A

14.14.1 COMPANY SNAPSHOT

14.14.2 PRODUCT PORTFOLIO

14.14.3 RECENT DEVELOPMENTS

14.15 SAFERSONIC

14.15.1 COMPANY SNAPSHOT

14.15.2 PRODUCT PORTFOLIO

14.15.3 RECENT DEVELOPMENTS

14.16 TURQUOISE HEALTH

14.16.1 COMPANY SNAPSHOT

14.16.2 PRODUCT PORTFOLIO

14.16.3 RECENT DEVELOPMENTS

15 QUESTIONNAIRE

16 RELATED REPORTS

표 목록

TABLE 1 EUROPE ULTRASOUND GELS MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 2 EUROPE ULTRASOUND GELS MARKET, BY TYPE, 2020-2029 (VOLUME, IN THOUSAND)

TABLE 3 EUROPE ULTRASOUND GELS MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 4 EUROPE ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 5 EUROPE ABDOMINAL ULTRASOUND IN ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 6 EUROPE OBSTETRIC ULTRASOUND IN ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 7 EUROPE HYSTEROSONOGRAPHY IN ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 8 EUROPE PELVIC ULTRASOUND IN ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 9 EUROPE MUSCULOSKELETAL ULTRASOUND IN ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 10 EUROPE BREAST ULTRASOUND IN ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 11 EUROPE PROSTATE ULTRASOUND IN ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 12 EUROPE CAROTID ULTRASOUND IN ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 13 EUROPE VENOUS ULTRASOUND (EXTREMITIS) IN ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 14 EUROPE SCROTAL ULTRASOUND IN ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 15 EUROPE THYROID ULTRASOUND IN ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 16 EUROPE ULTRASOUND GELS MARKET, BY END USER, 2020-2029 (USD THOUSAND)

TABLE 17 EUROPE ULTRASOUND GELS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD THOUSAND)

TABLE 18 EUROPE ULTRASOUND GELS MARKET, BY COUNTRY, 2020-2029 (USD THOUSAND)

TABLE 19 GERMANY ULTRASOUND GELS MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 20 GERMANY ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 21 GERMANY ABDOMINAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 22 GERMANY OBSTETRIC ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 23 GERMANY HYSTEROSONOGRAPHY ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 24 GERMANY PELVIC ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 25 GERMANY MUSCULOSKELETAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 26 ERMANY BREAST ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 27 GERMANY PROSTATE ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 28 GERMANY CAROTID ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 29 GERMANY VENOUS ULTRASOUND (EXTERMITIS) GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 30 GERMANY SCROTAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 31 GERMANY THYROID ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 32 GERMANY ULTRASOUND GELS MARKET, BY END USER, 2020-2029 (USD THOUSAND)

TABLE 33 GERMANY ULTRASOUND GELS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD THOUSAND)

TABLE 34 FRANCE ULTRASOUND GELS MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 35 FRANCE ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 36 FRANCE ABDOMINAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 37 FRANCE OBSTETRIC ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 38 FRANCE HYSTEROSONOGRAPHY ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 39 FRANCE PELVIC ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 40 FRANCE MUSCULOSKELETAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 41 FRANCE BREAST ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 42 FRANCE PROSTATE ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 43 FRANCE CAROTID ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 44 FRANCE VENOUS ULTRASOUND (EXTERMITIS) GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 45 FRANCE SCROTAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 46 FRANCE THYROID ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 47 FRANCE ULTRASOUND GELS MARKET, BY END USER, 2020-2029 (USD THOUSAND)

TABLE 48 FRANCE ULTRASOUND GELS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD THOUSAND)

TABLE 49 U.K. ULTRASOUND GELS MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 50 U.K. ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 51 U.K. ABDOMINAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 52 U.K. OBSTETRIC ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 53 U.K. HYSTEROSONOGRAPHY ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 54 U.K. PELVIC ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 55 U.K. MUSCULOSKELETAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 56 U.K. BREAST ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 57 U.K. PROSTATE ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 58 U.K. CAROTID ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 59 U.K. VENOUS ULTRASOUND (EXTERMITIS) GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 60 U.K. SCROTAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 61 U.K. THYROID ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 62 U.K. ULTRASOUND GELS MARKET, BY END USER, 2020-2029 (USD THOUSAND)

TABLE 63 U.K. ULTRASOUND GELS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD THOUSAND)

TABLE 64 ITALY ULTRASOUND GELS MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 65 ITALY ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 66 ITALY ABDOMINAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 67 ITALY OBSTETRIC ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 68 ITALY HYSTEROSONOGRAPHY ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 69 ITALY PELVIC ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 70 ITALY MUSCULOSKELETAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 71 ITALY BREAST ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 72 ITALY PROSTATE ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 73 ITALY CAROTID ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 74 ITALY VENOUS ULTRASOUND (EXTERMITIS) GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 75 ITALY SCROTAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 76 ITALY THYROID ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 77 ITALY ULTRASOUND GELS MARKET, BY END USER, 2020-2029 (USD THOUSAND)

TABLE 78 ITALY ULTRASOUND GELS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD THOUSAND)

TABLE 79 TURKEY ULTRASOUND GELS MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 80 TURKEY ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 81 TURKEY ABDOMINAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 82 TURKEY OBSTETRIC ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 83 TURKEY HYSTEROSONOGRAPHY ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 84 TURKEY PELVIC ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 85 TURKEY MUSCULOSKELETAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 86 TURKEY BREAST ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 87 TURKEY PROSTATE ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 88 TURKEY CAROTID ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 89 TURKEY VENOUS ULTRASOUND (EXTERMITIS) GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 90 TURKEY SCROTAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 91 TURKEY THYROID ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 92 TURKEY ULTRASOUND GELS MARKET, BY END USER, 2020-2029 (USD THOUSAND)

TABLE 93 TURKEY ULTRASOUND GELS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD THOUSAND)

TABLE 94 SPAIN ULTRASOUND GELS MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 95 SPAIN ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 96 SPAIN ABDOMINAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 97 SPAIN OBSTETRIC ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 98 SPAIN HYSTEROSONOGRAPHY ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 99 SPAIN PELVIC ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 100 SPAIN MUSCULOSKELETAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 101 SPAIN BREAST ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 102 SPAIN PROSTATE ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 103 SPAIN CAROTID ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 104 SPAIN VENOUS ULTRASOUND (EXTERMITIS) GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 105 SPAIN SCROTAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 106 SPAIN THYROID ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 107 SPAIN ULTRASOUND GELS MARKET, BY END USER, 2020-2029 (USD THOUSAND)

TABLE 108 SPAIN ULTRASOUND GELS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD THOUSAND)

TABLE 109 NETHERLANDS ULTRASOUND GELS MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 110 NETHERLANDS ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 111 NETHERLANDS ABDOMINAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 112 NETHERLANDS OBSTETRIC ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 113 NETHERLANDS HYSTEROSONOGRAPHY ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 114 NETHERLANDS PELVIC ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 115 NETHERLANDS MUSCULOSKELETAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 116 NETHERLANDS BREAST ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 117 NETHERLANDS PROSTATE ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 118 NETHERLANDS CAROTID ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 119 NETHERLANDS VENOUS ULTRASOUND (EXTERMITIS) GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 120 NETHERLANDS SCROTAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 121 NETHERLANDS THYROID ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 122 NETHERLANDS ULTRASOUND GELS MARKET, BY END USER, 2020-2029 (USD THOUSAND)

TABLE 123 NETHERLANDS ULTRASOUND GELS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD THOUSAND)

TABLE 124 BELGIUM ULTRASOUND GELS MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 125 BELGIUM ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 126 BELGIUM ABDOMINAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 127 BELGIUM OBSTETRIC ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 128 BELGIUM HYSTEROSONOGRAPHY ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 129 BELGIUM PELVIC ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 130 BELGIUM MUSCULOSKELETAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 131 BELGIUM BREAST ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 132 BELGIUM PROSTATE ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 133 BELGIUM CAROTID ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 134 BELGIUM VENOUS ULTRASOUND (EXTERMITIS) GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 135 BELGIUM SCROTAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 136 BELGIUM THYROID ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 137 BELGIUM ULTRASOUND GELS MARKET, BY END USER, 2020-2029 (USD THOUSAND)

TABLE 138 BELGIUM ULTRASOUND GELS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD THOUSAND)

TABLE 139 SWITZERLAND ULTRASOUND GELS MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 140 SWITZERLAND ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 141 SWITZERLAND ABDOMINAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 142 SWITZERLAND OBSTETRIC ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 143 SWITZERLAND HYSTEROSONOGRAPHY ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 144 SWITZERLAND PELVIC ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 145 SWITZERLAND MUSCULOSKELETAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 146 SWITZERLAND BREAST ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 147 SWITZERLAND PROSTATE ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 148 SWITZERLAND CAROTID ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 149 SWITZERLAND VENOUS ULTRASOUND (EXTERMITIS) GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 150 SWITZERLAND SCROTAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 151 SWITZERLAND THYROID ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)

TABLE 152 SWITZERLAND ULTRASOUND GELS MARKET, BY END USER, 2020-2029 (USD THOUSAND)

TABLE 153 SWITZERLAND ULTRASOUND GELS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD THOUSAND)

TABLE 154 REST OF EUROPE ULTRASOUND GELS MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

그림 목록

FIGURE 1 EUROPE ULTRASOUND GELS MARKET: SEGMENTATION

FIGURE 2 EUROPE ULTRASOUND GELS MARKET: DATA TRIANGULATION

FIGURE 3 EUROPE ULTRASOUND GELS MARKET: DROC ANALYSIS

FIGURE 4 EUROPE ULTRASOUND GELS MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS

FIGURE 5 EUROPE ULTRASOUND GELS MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE ULTRASOUND GELS MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 EUROPE ULTRASOUND GELS MARKET: DBMR MARKET POSITION GRID

FIGURE 8 EUROPE ULTRASOUND GELS MARKET: MARKET END-USER COVERAGE GRID

FIGURE 9 EUROPE ULTRASOUND GELS MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 EUROPE ULTRASOUND GELS MARKET: SEGMENTATION

FIGURE 11 THE INCREASING PREVALENCE OF ULTRASOUND PROCEDURES AND THE RISE IN THE GERIATRIC POPULATION ARE EXPECTED TO DRIVE THE EUROPE ULTRASOUND GELS MARKET IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 12 THE NON-STERILE ULTRASOUND GELS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE ULTRASOUND GELS MARKET IN 2022 & 2029

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE GLOBAL MRI COILS MARKET

FIGURE 14 EUROPE ULTRASOUND GELS MARKET: BY TYPE, 2021

FIGURE 15 EUROPE ULTRASOUND GELS MARKET: BY TYPE, 2022-2029 (USD THOUSAND)

FIGURE 16 EUROPE ULTRASOUND GELS MARKET: BY TYPE, CAGR (2022-2029)

FIGURE 17 EUROPE ULTRASOUND GELS MARKET: BY TYPE, LIFELINE CURVE

FIGURE 18 EUROPE ULTRASOUND GELS MARKET: BY APPLICATION, 2021

FIGURE 19 EUROPE ULTRASOUND GELS MARKET: BY APPLICATION, 2022-2029 (USD THOUSAND)

FIGURE 20 EUROPE ULTRASOUND GELS MARKET: BY APPLICATION, CAGR (2022-2029)

FIGURE 21 EUROPE ULTRASOUND GELS MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 22 EUROPE ULTRASOUND GELS MARKET: BY END USER, 2021

FIGURE 23 EUROPE ULTRASOUND GELS MARKET: BY END USER, 2022-2029 (USD THOUSAND)

FIGURE 24 EUROPE ULTRASOUND GELS MARKET: BY END USER, CAGR (2022-2029)

FIGURE 25 EUROPE ULTRASOUND GELS MARKET: BY END USER, LIFELINE CURVE

FIGURE 26 EUROPE ULTRASOUND GELS MARKET: BY DISTRIBUTION CHANNEL, 2021

FIGURE 27 EUROPE ULTRASOUND GELS MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD THOUSAND)

FIGURE 28 EUROPE ULTRASOUND GELS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)

FIGURE 29 EUROPE ULTRASOUND GELS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 30 EUROPE ULTRASOUND GELS MARKET: SNAPSHOT (2021)

FIGURE 31 EUROPE ULTRASOUND GELS MARKET: BY COUNTRY (2021)

FIGURE 32 EUROPE ULTRASOUND GELS MARKET: BY COUNTRY (2022 & 2029)

FIGURE 33 EUROPE ULTRASOUND GELS MARKET: BY COUNTRY (2021 & 2029)

FIGURE 34 EUROPE ULTRASOUND GELS MARKET: BY TYPE (2022 & 2029)

FIGURE 35 EUROPE ULTRASOUND GELS MARKET: COMPANY SHARE 2021 (%)

자세한 정보 보기 Right Arrow

연구 방법론

데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.

DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.

사용자 정의 가능

Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.

자주 묻는 질문

The Europe Ultrasound Gels Market is projected to grow at a CAGR of 6.1% during the forecast period by 2029.
The future market value of the Europe Ultrasound Gels Market is expected to reach USD 39,078.25 thousand by 2029.
The major players in the Europe Ultrasound Gels Market Medline Industries LP, Deas s.r.l, HR Pharmaceuticals Inc, FIAB SpA, Gima S.p.A, Parker Laboratories Inc, Primax Berlin GmbH, Optimum Medical Limited, Safersonic, Braun and Co. Limited, ProSys International Ltd, Turquoise Health, DJO LLC, Fannin, Lessa(Subsidiary of AB Medica Group), Rays S.P.A among others.
The country covered in the Europe Ultrasound Gels Market are Germany, France, U.K., Italy, Spain, Netherlands, Switzerland, Belgium, Turkey and the Rest of Europe.